Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
Acq. announced
NeurogesX Inc (NGSX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/30/2012 GN NeurogesX' NGX-1998 Well-Tolerated Treatment Demonstrated Clear Dose-Response in Patients
08/07/2012 GN NeurogesX Provides Regulatory Update for NGX-1998 Clinical Program
08/03/2012 GN NeurogesX Reports Second Quarter 2012 Results
07/27/2012 GN NeurogesX to Hold Conference Call to Discuss Second Quarter 2012 Results
07/16/2012 GN NeurogesX NGX-1998 Phase 2 Study Data to be Presented at World Congress on Pain
06/29/2012 GN Trading in NeurogesX Common Stock to Move From NASDAQ to OTCBB
06/18/2012 GN NeurogesX Issued Japanese Patent for NGX-1998
05/03/2012 GN NeurogesX Reports First Quarter 2012 Results
04/27/2012 GN NeurogesX to Hold Conference Call to Discuss First Quarter 2012 Results
04/20/2012 GN NeurogesX Receives Determination Letter From NASDAQ
04/17/2012 GN NeurogesX Engages JSB-Partners to Execute Business Development Strategy
04/11/2012 GN NeurogesX Provides Update on NGX-1998 Clinical Program
03/08/2012 GN NeurogesX Reports Fourth Quarter and Year-End 2011 Results
02/29/2012 GN NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Full Year 2011 Results
02/03/2012 GN NeurogesX Grants Equity Awards Under Its 2011 Inducement Stock Plan
02/01/2012 GN NeurogesX, Inc. Announces $3.0 Million Private Placement
01/03/2012 GN NeurogesX Appoints Ronald Martell President and Chief Executive Officer
10/31/2011 GN NeurogesX Reports Third Quarter 2011 Results
10/31/2011 GN NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
10/27/2011 GN NeurogesX to Hold Conference Call to Discuss Third Quarter 2011 Results
09/08/2011 GN NeurogesX Submits Supplemental New Drug Application for Qutenza(R) (capsaicin) 8% Patch for HIV-Associated Peripheral Neuropathy (HIV-PN)
09/01/2011 GN NeurogesX to Participate in Two Investor Healthcare Conferences in September 2011

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy